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Next-Generation sequencing (NGS) has highlighted the limitations of conventional culture 
methods in the role of urology whilst discovering the intricate details of the role of 
microbiota in urologic health and disease. This review article explores: the utility and 
limitations of conventional culture methods; how culture-independent technologies are 
revolutionising medicine; and how the implementation of these technologies may lead to 
improved patient outcomes.  Finally, this article discusses the barriers to widespread 





History of culture methods 
Since the inception of conventional culture methods by Dr Robert Koch in the 1880s, 
traditional microbiology has played an integral role in the identification of bacterial 
pathogens. With antimicrobial resistance an ever-growing concern, it is important 
that we determine whether we can rely on culture and sensitivity to accurately 
diagnose episodes of infection and, if so, when it is appropriate for such reliance on 
this traditional method. 
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Before the use of vaccines, the story of infection was relatively simple – planktonic 
bacteria would seek to penetrate the external defences of the human body, 
overcome the internal defences of the host, subsequently reaping a potentially 
ghastly infection. Fortunately for traditional culture methods, these bacteria typically 
possessed cell walls which exhibited great survival ability in various environments, 
lacked cell-to-cell connections, and often had adaptations which allowed them to 
adhere to surfaces1. Culture methods, therefore, have successfully aided the 
development and selection of antibiotics, eradicating many epidemic diseases, 
saving a great deal of human life. 
 
The present day 
However, the efficacy of such methods has ultimately led to their own demise – 
colonization and survival are now achieved, primarily, through the creation of 
biofilms1. This is the term given to “architecturally complex microbial communities 
that grow adhered to surfaces and are encased by an extracellular matrix”2. Biofilms 
were recognised due to their persistent nature and their resistance to antibiotic 
therapies. There is now consensus among the microbiology community that only 1% 
of microorganisms present in natural and pathogenic ecosystems are planktonic - 
the remaining 99% grow as a biofilm3. The Centers for Disease Control and 
Prevention has estimated that approximately 65% of all bacterial infections, and an 
even higher 80% of chronic infections are made up of biofilm infections1,4. These 
statistics suggest that the overwhelming majority of micro-organisms exist in 
communities with cell-to-cell connections. Importantly, cells within a biofilm exhibit a 
crucial difference from planktonic bacteria – they fail to create colonies when single 
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species biofilms have been removed from their microenvironment and set upon 
traditional petri dishes5. 
 
Naturally, such a failure to produce colonies will ultimately lead to a „negative‟ result 
on culture. It is straightforward to see how this can occur  patients presenting with 
chronic biofilm infections are often recipients of previous courses of antibiotics; such 
antimicrobial treatment will have eradicated the planktonic bacteria which would 
otherwise have been suggestive of an infection, rendering any new culture 
„negative‟, despite the presence of a flourishing biofilm. These false negatives are 
not unimportant; since culture methods are the only widely available diagnostic tools 
used for the identification of micro-organisms for most institutions in the developed 
world, many millions of people each year are susceptible to hidden, protracted 
infections. This is a growing problem and poses a serious dilemma for clinicians 
tasked with the care of a patient who, by any reasonable clinical criteria, is suffering 
from an indolent infection, but whose culture results continuously return as 
„negative‟. Combining such a fundamental limitation with the inherently slow nature 
of culture methods, it is not uncommon for a healthcare practitioner to be making 
what amounts to a „best guess‟ as to which antibiotic is most appropriate for a given 
patient, without knowing the identity and characteristics of the culpable 
microorganism(s). Such clinicians inevitably find themselves in a proverbial „catch 
22‟, expected to be advocates of antibiotic stewardship, with a tool that cannot be 
relied upon to provide timely, accurate information. Ultimately, this dilemma can have 
several important ramifications: (1) inefficient use of resources including money, 
expertise of well-trained microbiologists, and time; (2) contribution to antimicrobial 
resistance due to the use of inappropriate treatment regimens; (3) microbiota 
         
 5 
impairment – e.g. ciprofloxacin and vancomycin have been shown to alter the 





Dysuria is a common complaint for women attending an appointment in general 
practice. The majority of these cases are associated with significant bacteriuria7. 
Usually, empirical antibiotics are started without the need for a urine culture, as 
classical symptoms such as dysuria, urgency, and frequency, correctly predict a 
urinary tract infection (UTI) at a high rate8. Indeed, Public Health England guidance 
suggests that a urine culture is normally redundant in females presenting with two or 
three symptoms of UTI and recommends the prescription of empirical antibiotics 
without further testing9. 
 
Thresholds, contamination, and areas of contention 
Despite the high-predictive value of such classical symptoms indicating active 
infection, approximately ¼ of symptomatic women will produce a urine culture 
eventually labelled as „negative‟ according to the cut-off threshold used7. There has 
been considerable debate over what ought to constitute a „positive‟ urine culture, 
with scepticism over the time-honoured threshold of 105 CFU/mL in cases of 
suspected uncomplicated UTI10. This debate boils down to concerns over the 
potential lack of sensitivity in diagnosing a UTI, contrasted with the desire to avoid 
overdiagnosis and subsequent treatment of unimportant cases of bacteriuria. Even 
the more liberal threshold of 103 CFU/mL is likely to fail in detecting sexually 
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transmitted infections11. Over 30 years ago, it was proposed that an even lower 
threshold of 102 CFU/mL may be suitable for a diagnosis of uncomplicated UTI in 
women experiencing symptoms10. There appears to be very little consensus over an 
appropriate cut-off for the diagnosis of UTI; indeed, it has been suggested that there 
is, in fact, no definitive bacterial count which can be considered conclusive for all 
cases of UTI12. 
 
A further concern over culture and sensitivity is its high susceptibility to 
contamination13. Cultures are typically viewed as „spoiled‟ if more than two isolates 
of 103 CFU/mL are detected14. In the United States, the average institution reports a 
15% contamination rate of urine cultures14. Opposing research has complicated 
matters, with authors in the 1960s espousing that low bacterial counts can be 
considered as contamination15,16, while others, only a few years later, demonstrated 
that symptomatic women rather frequently had low colony forming units17,18. A lack of 
consensus over what threshold constitutes an infection, combined with seemingly 
high rates of contamination only serves to complicate matters for a clinician. Indeed, 
a strongly contested issue has arisen from this inability to provide a clear answer as 
to whether there is infection, or mere contamination - „urethral syndrome‟19. This 
term refers to those patients who suffer from symptoms typical of a lower urinary 
tract infection but fail to produce a „positive‟ urine culture. Such terminology is still 
utilised today, commonly described as idiopathic, with bacterial and viral agents not 
thought to be the cause20. Interestingly, 20 years ago, it was demonstrated that, 
despite being classified as entirely separate entities, with supposedly differing 
aetiologies, outcomes were equal between those diagnosed with UTI versus those 
diagnosed with urethral syndrome, after antibacterial treatment had been 
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administered21. This finding suggests that there may be a similar aetiology, one of 
infection, and it is possible that queries over thresholds have made the issue more 
complex than it ought to have been. 
 
It is apparent that standard microbiology methods have many downsides: they are 
unable to detect anaerobic bacteria in cases of UTI due to the difficulty in growing 
such pathogens via traditional methods; they struggle to detect microbes such as 
Aeroccocus urinae, Gardnerella vaginalis etc., as such species can only be caught 
using particular media types and prolonged incubation periods22,23; and certain 
strains of E. coli, for example, exist as intracellular biofilms, rendering the host 
symptomatic, whilst simultaneously hiding from conventional culture methods24. 
Evidently, therefore, the use of cultures in the detection and identification of complex, 
diverse, microbial communities existing as biofilms is limited. 
 
Introduction to PCR and NGS 
Polymerase chain reaction (PCR) was developed by Kary Mullins in 1983 and its 
benefits were immediately evident. Compared to culture, PCR is faster, cheaper, and 
more accurately detects organisms in a sample25. PCR works in a three-step 
process: 
 
1) initial hot denaturation of a double-stranded DNA template 
2) annealing of specific primers on the target 
3) extending the annealed primers with DNA polymerase 
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These DNA templates are then amplified to a sufficient degree to identify the 
pathogens. The high sensitivity and specificity of PCR have enabled the detection of 
rare microbial targets which has driven its diagnostic clinical applications, specifically 
in the identification of body fluid infections26-28. In the past decade, a multiplex PCR 
was introduced which enabled direct-from-urine analysis, both identifying more 
bacteria and discriminating more fastidious bacteria than traditional urine culture in 
patients with symptoms of UTI29,30.  
 
Next Generation Sequencing (NGS) is the first cost-effective approach to 
sequencing human samples for medical genetics and diagnostic purposes31. Also 
known as high-throughput sequencing, NGS can sequence the DNA and RNA of a 
given sample and is considered revolutionary because it can compute an entire 
human genome in a day, compared to the previous Sanger sequencing which would 
take 10 years32.  NGS can be used to characterise a particular microbiome, such as 
the urinary microbiome, by comparing these sequences to known motifs specific to 
certain microorganisms33. NGS provides information on which bacteria and fungi are 
present in the sample, the bacterial load of each microorganism, and antibiotic 
resistance genes. This diagnostic tool can allow for more targeted clinical therapy by 
considering the predominant pathogen causing the infection and potential antibiotic 
resistance.  
 
The utility of culture-independent microbiology 
 
Urine samples 
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It was not long ago that the medical community held the dogmatic belief that urine is 
sterile. With the use of DNA-sequencing technologies, this is now known not to be 
the case, with several studies demonstrating the presence of multiple bacteria in 
healthy volunteers. One such example was provided by McDonald et al., where 22 
healthy volunteers provided urine samples for analysis by NGS. In 5/22, culture 
results were positive; according to NGS, 21/22 had bacteria detected in their urine, 
despite being asymptomatic34. Although this raises more questions about the normal 
composition of the urinary microbiome than it does answers, knowledge in this field 
is increasing at an impressive rate. As a result, interest has begun to turn towards 
the role of the microbiota in the pathogenesis of numerous conditions35. 
 
Pearce et al. produced intriguing work on the comparison of the urinary microbiome 
in women with and without urgency urinary incontinence (UUI)23. Previously, Pearce 
and colleagues had demonstrated that bacteria that had classically been missed by 
conventional culture methods could be grown by expanded quantitative urine culture 
(EQUC)36. However, EQUC is still not sufficient to detect and identify many bacteria 
which reside within the urinary tract23. As a result, this group of researchers used 
high-throughput sequencing of the 16S rRNA gene and EQUC to explore urine 
samples from transurethral catheters in women with UUI and to compare the findings 
with a control group of women without UUI. Sequencing results revealed bacterial 
DNA in approximately 65% of women in each group. In comparison to other studies, 
this overall detection rate seems relatively low, but this could possibly have several 
explanations e.g. primer errors, low bacterial load etc. This study produced several 
statistically significant findings23: 
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(1) reduced frequency of Staphylococcus within the UUI group 
(2) higher frequency of Gardnerella and Aerococcus within the UUI group 
(3) reduced abundance of Lactobacillus within the UUI group 
(4) increased abundance of Gardnerella within the UUI group 
(5) Lactobacillus gasseri was found more frequently in the UUI group 
(6) Lactobacillus crispatus was found less frequently in the UUI group 
 
A majority (78.9%) of urine samples grew bacteria when cultivated by EQUC. Of 
note, 90.1% of these EQUC-positive samples failed to grow on standard culture. The 
authors discussed that, in this study, the type II error of standard culture was 90.3% 
in the UUI group, and a similar 90.0% in the control group. This study, however, 
suggests a degree of superiority of EQUC over sequencing as evidenced by the 
following results: 
 
 EQUC was capable of detecting bacteria in 14/19 sequence-negative 
specimens 
 DNA sequencing detected bacteria in 3/8 EQUC-negative specimens 
 
With that said, it is worth pointing out that certain genera were detected by DNA 
sequencing but failed to grow even on EQUC. Evidently, even the most 
comprehensive culture methods fail to detect particular bacteria. Although EQUC did 
out-perform NGS in the detection of a total of 9 genera, sequencing successfully 
detected those same genera in other urine samples, suggesting that this apparent 
limitation could be overcome by alteration in the amplification of primers23. 
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Heytens et al. compared the mid-stream urine samples of 86 asymptomatic women 
and 220 women with symptoms suggestive of UTI using culture methods and 
quantitative PCR (qPCR)37. Overall, 95.9% of the symptomatic women were qPCR-
positive for E. coli while, in the same group, E. coli or another uropathogen was only 
cultured in 80.9% of the samples. In the asymptomatic group, 11.6% of women had 
a positive urine sample on qPCR – almost the exact same proportion of those with 
positive cultures (10.5%). This suggests that the large difference in positive results 
between culture and qPCR in the symptomatic group cannot be attributed to 
contamination as a result of improved sensitivity of qPCR. Additionally, 90.5% of the 
42 symptomatic women with negative cultures had a positive qPCR result, while only 
5.3% of the 76 asymptomatic women with negative cultures had a positive qPCR 
result (p <0.0001). 
 
McDonald et al. compared conventional culture methods and NGS in the treatment 
of 44 patients with symptoms of acute cystitis34. Patients were randomised into two 
arms. Arm A was treated based on results of culture, while Arm B was treated based 
on results of NGS. If cultures were negative in Arm A, patients were treated 
according to results of NGS. Overall, 29.5% (13/44) of urine samples were positive 
on culture, compared to 100% of samples on NGS. Interestingly, NGS demonstrated 
that 77% of samples were polymicrobial, compared to only 15% of positive cultures. 
Symptom scores (based on a UTI self-assessed questionnaire) were significantly 
better in Arm B (NGS-based group). Of clinical importance was the ability of NGS to 
detect anaerobic bacteria; such species were present in 45.5% of samples and, in 
50% of those cases, anaerobic bacteria constituted the main infectious component of 
the urine. 
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At the European Association of Urology Congress in March 2019, Dixon et al. 
presented work assessing the comparative value of standard culture and sensitivity 
versus NGS in chronic UTI38. A total of 69 patients were included, all of whom 
received NGS on their mid-stream catch urine samples. 49/69 patients also had 
culture and sensitivity performed, allowing a comparison between the two methods 
of diagnosis in 49 patients. Overall, NGS detected a microbial presence in 98.6% 
(68/69) of patients, while culture and sensitivity only produced a positive result in 
61% (30/49) of patients. In the single case of an NGS-negative result, culture 
methods did detect the presence of an organism. In the 19 culture-negative cases, 
NGS detected microbes in 18. A single patient produced a negative result on both 
tests. 
 
Lewis et al. assessed MSU samples from healthy males (n =6) and healthy females 
(n=10)39. Their work showed a trend towards a heterogenous mix of bacterial genera 
within females, with a larger range of genera, and a greater diversity of genera on 
average, at a level that was statistically significant (p = 0.042). Of significant 
importance was the ability of NGS to detect and identify organisms that would not be 
grown by conventional culture methods; the authors explained that NGS results 
revealed 94 bacterial genera, 63 of which would either not usually be cultivated by 
National Health Service laboratories or would not be reported individually. Their work 
also produced the first report of the presence of the genus Soehngenia in humans. 
NGS detected this in 4 individuals, 3 of whom were female. Once again, such a 
finding would not have been observed if dependent on conventional culture methods, 
as bacteria within this genus are anaerobic.  
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Liss et al. explored the role of NGS in the selection of prophylactic antibiotics for 
ureteroscopy40. 20 patients provided urine samples for culture and NGS prior to 
surgery. Cultures returned positive for just 2/20 samples, while NGS provided 
positive results in 12/20. In the 18 culture-negative cases, NGS revealed the 
presence of microbes in 10. In the 2 culture-positive samples, NGS concurred and 
produced a positive result. 
 
Shrestha et al. sought to explore any association between the urinary microbiome 
and the presence of prostate cancer, grading of said cancer, as well as the type of 
prostatic inflammation in men undergoing prostate biopsy41. Their work revealed that 
men with prostate cancer more commonly exhibited bacteria associated with 
infections of the urogenital tract such as prostatitis. Some bacteria were also noted 
to be more prevalent in those with higher grade prostate cancer e.g. Streptococcus. 




Culture-independent methods have recently been used to examine the microbial 
composition of rectal samples, showing that men receiving anti-androgen therapy for 
prostate cancer had different microbiota to those being treated with only GnRH 
therapies or not being treated at all42. There has been some evidence, also 
produced by NGS, that there is no difference in the rectal bacterial profiles of men 
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with prostate cancer and those without, with the exception of an elevated frequency 
of Bacteroides and Streptococcus in men with prostate cancer43. 
Preliminary work has also been carried out using NGS to create individualised 
antimicrobial prophylaxis for men undergoing TRUS-guided prostate biopsy44. 
Although only performed with a small sample of 68 participants, this method of 
precision-prophylaxis resulted in a complete avoidance of severe infectious 
complications (0/68) at 30 days post-procedure. This is in contrast to the usual rate 
of complications which can be as high as 17%45.  
 
Limitations of PCR 
 
Although PCR enables amplification of bacterial species, it can still be challenging to 
diagnose a bacterial infection that has multiple aetiologies. In the diagnosis of UTI, 
PCR is limited to the detection of a single pathogen or the gram-status46. PCR does 
not allow determination of a causal agent for an infection and necessitates multiple 
individual amplifications and analyses. Because of this, drug susceptibility and 
genetic typing still need to be performed; thus, PCR testing alone may be limited as 
a diagnostic tool. This issue has been addressed with the advent of multiplex real-
time PCR, which has sensitivity to 25 common bloodstream pathogens46.  
 
Another limitation of PCR is the likelihood of false positive and negative results. 
When urine is collected using the most common “clean catch” method, bacteria 
within the sample could be contaminated by commensal urethral flora30. PCR reports 
the presence of bacteria but does not quantify this; therefore, it can be difficult to 
discern physiologic bacteria contaminating the sample from a potential causative 
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agent of infection. Another false positive result can involve the detection of a 
pathogen by PCR in the absence of clinical UTI symptoms. It is unclear if this would 
represent a subclinical or passed infection and how clinically relevant this would 
be46. One of the most important limitations of PCR, however, is that it relies upon a 
„targeted detection methodology‟, whereby prior knowledge is used to put forward a 
hypothesis as to which aetiological agent is likely to be found, with subsequent 
primer development and utilisation in the effort to identify the aetiological microbe. 
High-throughput DNA sequencing does not assume this methodology and so is 
capable of circumventing this problem entirely, providing a thorough description of all 
the genomic content of a sample.  
 
Limitations of NGS 
 
Despite the revolutionary diagnostic relevance NGS provides, there are limitations of 
NGS of which providers should be aware. NGS has a high sensitivity for bacterial 
and fungal species, making it difficult to interpret the results and discerning their 
clinical relevance. The NGS panel states the bacteria and its dominance (proportion) 
in the sample. The issue with this structure is the potential inference that the 
dominant bacteria are the causative bacteria; however, the dominance of a 
microorganism does not mean it is pathophysiological, especially in the case of UTIs 
which have multiple different aetiologies. This issue encourages NGS companies to 
provide certain thresholds and physiologic percentages that allow clinicians to have 
a reference point for diagnosis.  
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Another limitation of NGS is its inability to test for phenotypic antibiotic sensitivity. 
Although NGS can determine a genetic link between antibiotic resistance and the 
sample DNA, the genotypic-phenotypic link is not clear47. There are some studies 
that have shown a correlation between genetic and phenotypic antibiotic resistance, 
but virulence determinants of resistance are still being developed33, 48. From these 
studies, it is clear that NGS can provide information on genetic susceptibility to 
antibiotic resistance, but the genetic and environmental factors responsible for an 
antibiotic resistant phenotype are not well understood. 
 
Finally, one of the most crucial impediments to widespread implementation of NGS is 
the quality of the data available for the genomic reference library. Publicly available 
databases are, unfortunately, impaired by incorrect annotations of data – the 
importance of this must not be understated, as the accuracy of the databases upon 
which healthcare providers must rely is of the highest priority due to its effects on the 
ability to correctly identify the organisms culpable for infection49. In order for NGS 
platforms to be used in everyday practice, this problem must be overcome by 
comprehensive quality control, and it is likely that regulatory bodies would need to be 
included in this49. 
Conclusion 
 
Conventional culture methods have proven invaluable since their discovery in the 
late 1800s. Today, still, they are used as the gold-standard diagnostic tool in even 
the most developed regions of the world. However, with the continuous improvement 
of culture-independent technologies such as NGS, it is evident that there are several 
areas in which culture methods are substantially inferior: an inability to detect the 
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entire spectrum of microbes present within a sample; high rates of false-negatives; 
difficulty detecting anaerobic microbes without extended techniques; high rates of 
contamination; slow to produce results; and biofilms, which now comprise the 
majority of infections, are capable of avoiding detection. Furthermore, there is now a 
wealth of information in the public domain which serves to demonstrate the utility of 
DNA-sequencing methods in the exploration of the urinary and rectal microbiomes, 
their complex interactions, and their potential role in the pathophysiological 
processes of a great number of urological diseases. Although not without their own 
limitations such as inaccuracies within reference databases, difficulty determining the 
culpable organism(s) from the spectrum of identified microbes, and the start-up costs 
for each medical centre, forthcoming advances will likely minimise these pitfalls. 
Such advances will likely be in the form of highly curated libraries, involvement of 
regulatory bodies in quality control, and ever-reducing costs. 
 
The idea that culture methods are incapable of appreciating the complexity of a 
bacterial ecosystem is not new  in the 1980s, environmental microbiologists noticed 
that less than 1% of bacteria in the natural ecosystem could be recovered using such 
means50. With the evolution and improvement of NGS platforms and bioinformatics, 
it is perhaps time to move on from traditional microbiology and begin implementing 
culture-independent technologies in day-to-day urological practice, with an aim to 
develop personalised therapeutic regimens.  
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Table 1. Summary of studies using culture-independent methods and their main 
findings 
Study Design Population 
type 
Main findings 
McDonald et al., 
201734 
Randomised Acute cystitis NGS was superior to culture in 
detection of organisms. 
Treatment based on NGS 
results was also more effective 





EQUC was superior to both 
standard culture and NGS with 
regard to microbial detection. 
NGS did, however, detect 
several bacterial genera that 
EQUC did not reveal 
Heytens et al., 
201737 
Observational Acute cystitis Quantitative PCR out-
performed standard culture in 
detection of organisms 
Dixon et al., 
201938 
Observational Chronic UTI NGS detected microbes more 
readily than standard culture 
methods 





NGS detected and successfully 
identified 63 bacterial genera 
that would not have been 
detected by standard culture 
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methods 





Compared to standard culture 
methods, NGS more readily 
detected urinary microbes 




NGS allowed the discovery that 
microbes associated with 
urogenital infection are more 
frequently seen in men with 
prostate cancer than in those 
without prostate cancer 
 
 
         
